Jeff Jonker
Chief Business Officer
Jeff joined Satori as CBO in 2010. Prior to joining Satori, Jeff was most recently Vice President of Business Development and Strategic Planning for Gloucester Pharmaceuticals (acquired by Celgene). Previously, Jeff served with Genentech in increasing positions of responsibility within both the Business Development and Corporate Legal groups, most recently as Group Director for Business Development and a member of Genentech's Immunology leadership team. Prior to Genentech, Jeff was an attorney in the Technology Transactions Group of Wilson, Sonsini, Goodrich & Rosati, representing private and public company clients in both the life science and high tech industries. Jeff holds degrees from Columbia University, the University of St. Andrews, and Claremont McKenna College.